Company Filing History:
Years Active: 2003-2016
Title: Arnfinn Andersen: Innovator in Radiopharmaceutical Quality Control
Introduction
Arnfinn Andersen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of radiopharmaceuticals, particularly in quality control systems. With a total of 2 patents, his work has advanced the methods used in the preparation and testing of pharmaceutical compositions.
Latest Patents
Andersen's latest patents include innovative technologies that enhance the quality control of radiopharmaceuticals. One of his patents describes a quality control ('QC') system for PET or SPECT radiopharmaceuticals. This system features a disposable, no-leakage, self-contained QC cassette that interfaces with the QC system. The design includes a shield that surrounds the cassette, ensuring both the area and the cassette are protected. The QC cassette is equipped with components for conducting various QC tests, including sensors and devices that perform these tests. Additionally, the QC system can generate a QC report that contains the test results.
Another significant patent by Andersen outlines a process for preparing contrast agents. This process involves creating an aqueous dispersion of gas-containing vesicles with membranes made from an amphiphilic membrane-forming material. The steps include generating a liquid dispersion, lyophilizing it, and then reconstituting it with a sterile aqueous liquid. The final product is a substantially aggregate-free sterile aqueous dispersion of gas-containing vesicles.
Career Highlights
Throughout his career, Arnfinn Andersen has worked with prominent companies such as Amersham Health AS and General Electric Company. His experience in these organizations has contributed to his expertise in the field of radiopharmaceuticals and quality control systems.
Collaborations
Andersen has collaborated with notable coworkers, including Ingrid Henriksen and Vera Kasparkova. Their combined efforts have furthered advancements in the technologies related to radiopharmaceuticals.
Conclusion
Arnfinn Andersen's contributions to the field of radiopharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor. His work continues to influence the quality control processes in the pharmaceutical industry.